Clinical trials in cancer

Clinical Cancer Research

Volumn 3, Issue 12 II, 1997, Pages 2585-2586

  Holland, James F ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; CISPLATIN; DOXORUBICIN; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER RESEARCH; CHILDHOOD LEUKEMIA; CHORIOCARCINOMA; CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG RESEARCH; HODGKIN DISEASE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; OSTEOSARCOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TESTIS CANCER;

CLINICAL PROTOCOLS; HUMANS; NEOPLASMS; OBSERVER VARIATION; RANDOMIZED CONTROLLED TRIALS; RESEARCH;

EID: 0031409278     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Li, M. C., Hertz, R., and Spencer, D. B. Effect of methotrexate on choriocarcinoma and chorioadenoma. Proc. Soc. Exp. Biol. Med., 93: 361, 1956.
2. Selawry, O. S., Hananian, J., Wolman, I. J., Abir, E., Chevalier, L., Gourdeau, R., Denton, R., Gussoff, B. D., Levy, R., Burgert, O., Jr., Mills, S. D., Blom, J., Jones, B., Patterson, R. B., McIntyre, O. R., Haurani, F. I., Moon, J. H., Hoogstraten, B., Kung, F. H., Sheehe, P. R., Frei, E., III, and Holland, J. F. New treatment schedule with improved survival in childhood. Intermittent parenteral vs daily oral administration of methotrexate for maintenance of induced remission. J. Am. Med. Assoc., 194: 75-81, 1965.
3. DeVita, V., Serpick, A., and Carbone, P. Combination of chemotherapy in the treatment of advanced Hodgkin's disease. Ann. Intern. Med., 73: 881-895, 1970.
4. Einhorn, L., and Donohue, J. cis-Diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann. Intern. Med., 87: 293-298, 1977.
5. Rosen, G., Murphy, M. L., Huvos, A. G., Gutierrez, M., and Marcove, R. C. Chemotherapy, en bloc resection and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer (Phila.), 37: 1-11, 1976.
6. Link, M. P., Goorin, A. M., Miser, A. W., Green, A. A., Pratt, C. B., Belasco, J. B., Pritchard, J., Malpas, J. S., Baker, A. R., Kirkpatrick, J. A., Ayala, A. G., Shuster, J. J., Abelson, H. T., Simone, J. V., and Vietti, T. J. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N. Engl. J. Med., 314: 1600-1606, 1986.
7. Bailar, J. C., III, Brown, B. W., Jr., DeCosse, J. J., Gehan, E. G., and Holland, J. F. Issues in the design of clinical trials. In: V. Mike and K. E. Stanley (eds.), Statistics in Medical Research, Methods and Issues, with Applications in Cancer Research, pp. 189-221. New York: John Wiley & Sons, 1982.
8. Holland, J. F. Chemotherapy of gigacytomas: the treatment and curability of "solid" tumors with drugs. In: Joseph H. Burchenal and Herbert F. Oettgen (eds.), Cancer Achievements, Challenges and Prospects for the 1980s, Vol. 2, pp. 563-583. Orlando, FL: Grune and Stratton, Inc., 1981.